Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The Oxford GBD (Global Burden of Disease) Group was established in July 2018 at the University of Oxford's Big Data Institute to work in partnership with the Institute for Health Metrics and Evaluation (IHME) at the University of Washington to conduct strategic research in epidemiology and public health.

Our flagship project, GRAM (Global Research on Antimicrobial Resistance), is supported by the UK Department of Health, the Bill and Melinda Gates Foundation and the Wellcome Trust to provide rigorous quantitative evidence of antimicrobial resistance to increase global awareness, boost surveillance efforts and promote the rational use of antimicrobials worldwide. This evidence will assist policy-makers in achieving future reductions in morbidity, mortality and other impacts associated with antimicrobial resistance.

GRAM is directed by Strategic Lead Prof Alan Lopez, who co-authored the seminal Global Burden of Disease Study in 1996 with IHME Director Prof Chris Murray. Prof Murray serves as Scientific Lead, alongside Prof Simon Hay of IHME and Dr Christiane Dolecek of the University of Oxford. Within Oxford, the BDI team is supervised by Senior Research Group Leader Dr Catrin Moore, with Dr Dolecek and Prof Susanna Dunachie providing expertise from the Centre for Tropical Medicine and Global Health. Prof Andy Stergachis is a senior investigator based at the University of Washington. Learn more about our research.